Simple exploration of tert-Butyl 4-(4-aminobenzoyl)piperazine-1-carboxylate

350684-49-0 tert-Butyl 4-(4-aminobenzoyl)piperazine-1-carboxylate 2763355, apiperazines compound, is more and more widely used in various fields.

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.350684-49-0,tert-Butyl 4-(4-aminobenzoyl)piperazine-1-carboxylate,as a common compound, the synthetic route is as follows.

General procedure: The mixture of compound 10a-10e (3.24 mmol), compound 9(1.04 g, 3.4 mmol), Pd(OAc)2 (0.11 g, 0.5 mmol), Xantphos (0.28 g,0.5 mmol), and K3PO41.38 g, 6.48 mmolin DMF (8 mL) was heated 22 h at 125 C under argon followed by cooling to roomtemperature.The mixture was extracted with dichloromethane(20 mL x 3), the combined organic phase was washed with water(15mL x 2), dried over anhydrous Na2SO4 and concentrated toafford the crude product. The crude product was purified by columnchromatography to obtain compounds 11a-11e. 4.1.6.1. Tert-butyl 4-(4-((5-chloro-4-((2-(methylcarbamoyl)phenyl)amino)pyrimidin -2-yl)amino)benzoyl)piperazine-1-carboxylate(11a). Yield 62%. MP: 227-228 C. 1H NMR (400 MHz, DMSO-d6)delta 11.64 (s, 1H), 9.73 (s, 1H), 8.77 (dd, J = 17.2, 4.4 Hz, 2H), 8.28 (s, 1H),7.78 (d, J = 8.8 Hz, 3H), 7.56-7.52 (m, 1H), 7.36 (d, J = 8.4 Hz, 2H),7.17 (t, J = 7.2 Hz, 1H), 3.50-3.36 (m, 8H), 2.83 (d, J = 4.4 Hz, 3H),1.42 (s, 9H).13C NMR (100 MHz, DMSO-d6) delta169.32, 168.87, 157.39,155.07, 154.53, 153.83, 141.78, 139.15, 131.45, 127.99, 122.13, 121.58, 121.01, 118.47, 105.80, 79.16, 43.56, 42.90, 28.02, 26.31., 350684-49-0

350684-49-0 tert-Butyl 4-(4-aminobenzoyl)piperazine-1-carboxylate 2763355, apiperazines compound, is more and more widely used in various fields.

Reference:
Article; Su, Yue; Li, Ridong; Ning, Xianling; Lin, Zhiqiang; Zhao, Xuyang; Zhou, Juntuo; Liu, Jia; Jin, Yan; Yin, Yuxin; European Journal of Medicinal Chemistry; vol. 177; (2019); p. 32 – 46;,
Piperazine – Wikipedia
Piperazines – an overview | ScienceDirect Topics